Fulcrum Therapeutics News

Fulcrum Therapeutics | EFFECT: Others

Apr 26 06:09 ET

Fulcrum Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 8 18:02 ET

Fulcrum Therapeutics | 424B5: Prospectus

Jan 18, 2023 17:08 ET

Fulcrum Therapeutics | 424B5: Prospectus

Jan 17, 2023 17:26 ET

Fulcrum Therapeutics | 424B5: Prospectus

Aug 16, 2022 17:55 ET

Fulcrum Therapeutics | 424B5: Prospectus

Aug 15, 2022 18:14 ET

Fulcrum Therapeutics | 424B5: Prospectus

May 9, 2022 21:54 ET

Fulcrum Therapeutics | EFFECT: Others

Apr 29, 2022 00:15 ET

Fulcrum Therapeutics | 424B5: Prospectus

Aug 12, 2021 16:38 ET

Fulcrum Therapeutics | 424B5: Prospectus

Aug 10, 2021 19:55 ET

Fulcrum Therapeutics | 424B5: Prospectus

Jan 20, 2021 16:02 ET

Fulcrum Therapeutics | 424B5: Prospectus

Jan 19, 2021 16:12 ET

Fulcrum Therapeutics | EFFECT: Others

Aug 18, 2020 00:15 ET

Fulcrum Therapeutics | EFFECT: Others

Aug 13, 2020 00:15 ET

Fulcrum Therapeutics | EFFECT: Others

Jul 8, 2020 00:16 ET

Fulcrum Therapeutics | 424B4: Prospectus

Jul 18, 2019 17:19 ET

Fulcrum Therapeutics | EFFECT: Others

Jul 18, 2019 00:15 ET

Fulcrum Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Jul 12, 2019 17:21 ET